AnaptysBio Inc - Company Profile
Powered by
All the data and insights you need on AnaptysBio Inc in one report.
- Save hours of research time and resources with
our up-to-date AnaptysBio Inc Strategy Report
- Understand AnaptysBio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
AnaptysBio Inc (AnaptysBio) focuses on the development of antibody candidates for the treatment of inflammatory, autoimmune, and atopic diseases. Its focus on research and development, collaboration and license agreements with GlaxoSmithKline and Bristol-Myers Squibb, and proprietary antibody discovery technology platform are its strengths, even as a history of operating losses could be a cause for concern. The company could benefit from the growing incidence of cancer, market potential of rare diseases and orphan drugs, and increasing healthcare expenditure in the US. However, its performance could be affected by stiff competition, uncertain R&D outcomes, and government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer